NIH Small Business Innovation Research (SBIR) Program (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-24-245) / (Parent SBIR [R43/R44] Clinical Trial Required) (PA-24-246) (Discontinued)

National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Program (Parent SIBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH). The NIH SBIR program supports small businesses to engage in innovative research that has the potential for commercialization. Research in macrophage metabolism could be relevant if it leads to novel diagnostic tools, therapies, or technologies.

NIH SBIR/STTR Parent SBIR (R43/R44) Clinical Trial Not Allowed (PA-24-245) is sponsored by National Institutes of Health (NIH). The NIH SBIR program supports small businesses developing innovative technologies that address health-related challenges through Phase I and Phase II funding, focusing on establishing technical feasibility, research and development, and advancing toward commercialization.

PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH). The NIH SBIR program provides seed funding to small businesses for research and development with strong potential for commercialization, including medical devices, with an emphasis on projects that do not include clinical trials. It aims to stimulate technological innovation and meet federal R&D needs. The program supports early-stage small businesses in bringing scientific innovations from the bench to the bedside.

PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS). This omnibus solicitation supports small businesses engaged in research and development with strong commercialization potential, addressing challenges faced by NIH populations experiencing health disparities. This includes technology and service innovations.

NIH Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA). This parent announcement supports researcher-initiated ideas for small business innovation research, covering a broad range of topics relevant to the missions of NIH, CDC, and FDA. It allows for clinical trials.